Maladaptive defense mechanisms moderate treatment outcome in 6 months versus 12 months dialectical-behavior therapy for borderline personality disorder.

borderline personality disorder defense mechanisms dialectical behavior therapy self-harm treatment length

Journal

Psychotherapy research : journal of the Society for Psychotherapy Research
ISSN: 1468-4381
Titre abrégé: Psychother Res
Pays: England
ID NLM: 9110958

Informations de publication

Date de publication:
22 Apr 2024
Historique:
medline: 23 4 2024
pubmed: 23 4 2024
entrez: 22 4 2024
Statut: aheadofprint

Résumé

We investigated whether defense mechanisms in patients with borderline personality disorder (BPD) predict treatment response of dialectical behavior therapy (DBT) and whether they moderate outcome in different treatment lengths. We analyzed a subsample of 60 outpatients with BPD, randomized into either 6 (n = 30) or 12 (n = 30) months of DBT. The average level of defensive adaptiveness, assessed with observer-rated overall defensive functioning (ODF) and "immature" (i.e., maladaptive) defenses were used as predictors and moderators of self-reported frequency of self-harm. We conducted a Generalized Linear Mixed Model (GLMM). A lower ODF at treatment onset predicted smaller reductions in self-harm, irrespective of treatment length ( Even though the results have to be regarded as preliminary due to the small sample size, findings might indicate that patients with BPD and lower average defensive adaptiveness may benefit from individualized treatment plans including specific interventions targeting defense function.

Identifiants

pubmed: 38648578
doi: 10.1080/10503307.2024.2334053
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-17

Auteurs

Sebastian Euler (S)

Department of Consultation Psychiatry and Psychosomatics, University Hospital of Zürich, Zürich, Switzerland.

Anna Babl (A)

Department of Clinical Psychology, Leiden University, Leiden, Netherlands.

Eliane Dommann (E)

Clinical Psychology and Psychotherapy Department, University of Bern, Bern, Switzerland.

Esther Stalujanis (E)

Department of Consultation Psychiatry and Psychosomatics, University Hospital of Zürich, Zürich, Switzerland.

Cathy Labrish (C)

Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.

Ueli Kramer (U)

Department of Psychiatry, Institute of Psychotherapy, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Shelley McMain (S)

Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.
Department of Psychiatry, University of Toronto, Toronto, ON, Canada.

Classifications MeSH